Quarterly report · Q3
4021.TEDINET S100SRRZ
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥155.3bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥228.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥159.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥33.4bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥38.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥35.0bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥55.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥35.7bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥26.0bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥41.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥30.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥26.1bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥31.0bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥309.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥298.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥276.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥88.4bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥77.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥221.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥221.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥216.2bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥25.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥29.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥25.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥25.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥33.7bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥37.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥11.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥25.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥186.02 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.44 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥291.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥217.99 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.21 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-12-31 | ¥18.3bn |
| Otherother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥7.3bn |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥11.0bn |
| Otherother segments | segment profit | 2023-04-01 → 2023-12-31 | −¥43m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥82.8bn |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2023-12-31 | −¥20.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥62.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥3.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥48.5bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥38.1bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥10.3bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥14.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥27.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥18.3bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥283m |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥61.9bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥49.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥12.3bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥17.4bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥57m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥77.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥57.7bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥19.4bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥238.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥175.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥62.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥37.3bn |
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥11.0bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥343m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥80.6bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-12-31 | −¥22.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥58.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥4.1bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥48.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥8.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥15.2bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥29.9bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.4bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥62.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥50.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥12.0bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥20.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥10m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥74.7bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥57.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥17.6bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥239.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥181.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥58.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥42.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 516
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes paid ope cf | CurrentYTDDuration | -15484000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 37767000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 33678000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -496000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -100000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 491000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 788000000 | JPY |
| Purchase of investments in subsidiaries inv cf | Prior1YTDDuration | -25000000 | JPY |
| Purchase of investments in subsidiaries inv cf | CurrentYTDDuration | -10000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -11753000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -12779000000 | JPY |
| Payments for retirement of property plant and equipment inv cf | Prior1YTDDuration | -508000000 | JPY |
| Payments for retirement of property plant and equipment inv cf | CurrentYTDDuration | -586000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -1012000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1251000000 | JPY |
| Net decrease increase in short term loans receivable inv cf | Prior1YTDDuration | 78000000 | JPY |
| Net decrease increase in short term loans receivable inv cf | CurrentYTDDuration | 2110000000 | JPY |
| Purchase of long term prepaid expenses inv cf | Prior1YTDDuration | -241000000 | JPY |
| Purchase of long term prepaid expenses inv cf | CurrentYTDDuration | -203000000 | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | 93000000 | JPY |
| Other net inv cf | Prior1YTDDuration | -3000000 | JPY |
| Other net inv cf | CurrentYTDDuration | 18000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -13470000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -11920000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -12032000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 7392000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -276000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -312000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -20084000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -22973000000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -105000000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | － | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -5002000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -5818000000 | JPY |
| Payments of money hold in trust for purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Payments of money hold in trust for purchase of treasury stock fin cf | CurrentYTDDuration | -4187000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -5000000 | JPY |
| Other net fin cf | CurrentYTDDuration | -0 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -37506000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -25899000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 1364000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 176000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -11845000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -3964000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 34658000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 29647000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YTDDuration | 3116000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYTDDuration | － | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 25928000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |